|
| Scientists reported that the cell-type-specific function of NKX2-1 was attributed to its differential chromatin binding that was acquired or retained during development in coordination with partner transcriptional factors. [Nature Communications] |
| |
|
|
PUBLICATIONSRanked by the impact factor of the journal |
|
|
|
| Investigators demonstrated a unique method for reconstitution of the functional human pulmonary alveoli in vitro, which was anticipated to pave the way for investigating relevant physiological and pathological events in the human distal lung. |
[Proceedings of the National Academy of Sciences of the United States of America] |
|
|
|
| Researchers investigated the molecular mechanism of enhancer of zeste homolog 2 (EZH2) in the development of asthma. [Laboratory Investigation] |
|
|
|
| Scientists aimed to characterize microvesicles shed from pneumolysin-stimulated alveolar epithelial cells and explored their contribution in mediating crosstalk with neutrophils. [Scientific Reports] |
| |
|
|
| Investigators analyzed 42 tissue biopsy samples from stage III/IV non-small cell lung cancer (NSCLC) patients by single cell RNA sequencing and presented the large scale, single cell resolution profiles of advanced NSCLCs. [Nature Communications] |
|
|
|
| Scientists found that GRHL1 was upregulated in non-small cell lung cancer and correlated with poor survival of patients. [Cell Death & Disease] |
|
|
|
| Carcinoid tumors with proven DIPNECH were associated with negative pathological features and might deserve a dedicated perioperative management. |
|
|
|
| Scientists identified regulators of intact amyloid-β40/42 levels in A549 and H1299 lung cancer cell media. [Scientific Reports] |
|
|
|
| Investigators described an effective approach through systemic injection of engineered polymer/DNA nanoparticles that mediated tumor-specific expression of a therapeutic gene, under the control of the cancer-selective progression elevated gene 3 promoter, to treat tumors in the lungs of diseased mice. [Scientific Reports] |
|
|
|
| Researchers investigated the acquired resistance mechanism of epidermal growth factor receptor (EGFR) kinase domain duplication against EGFR-tyrosine kinase inhibitors. [Cancer Research and Treatment] |
|
|
|
|
| The authors review data published with different thermal ablation (TA) techniques: radiofrequency ablation, microwave ablation and cryoablation. They also review the comparison that has been made between TA and stereotactic radiotherapy. [Current Oncology Reports] |
|
|
|
|
| CN Bio, Inc., announced the US FDA has extended their research collaboration, for a further three years. [CN Bio, Inc. (Business Wire, Inc.)] |
|
|
|
| ImmunoMet Therapeutics, Inc., announced that the US FDA has granted Fast Track designation for its lead compound IM156, an investigational Protein Complex 1 inhibitor, being evaluated for idiopathic pulmonary fibrosis. [ImmunoMet Therapeutics, Inc. (Business Wire, Inc.)] |
|
|
|
|
| July 12 – 15, 2021 Virtual |
|
|
|
|
|
| University of Exeter – Exeter, United Kingdom |
|
|
|
| University of Texas MD Anderson Cancer Center – Houston, Texas, United States |
|
|
|
| Helmholtz Zentrum München – Neuherberg (bei München), Germany |
|
|
|
| University of Chicago – Chicago, Illinois, United States |
|
|
|
| Thomas Jefferson University – Philadelphia, Pennsylvania, United States |
|
|
|
|